Quantum dot fluorescent microsphere immunochromatography test strip for detecting helicobacter pylori in excrement and preparation method of quantum dot fluorescent microsphere immunochromatography test strip
Immunochromatography test strips were constructed through anti-Herrellective pylori monoclonal antibodies labeled with quantum dot fluorescent microspheres, which solved the problem of equipment dependence and low sensitivity for detecting Helicobacter pylori infection in the prior art, and achieved rapid and accurate fecal samples Testing is suitable for home self-testing and prognostic efficacy monitoring, and has important clinical significance.
Patent Information
- Application Number
- CN202411128744.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-16
- Publication Date
- 2024-11-08
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
The prior art has problems such as invasive examination discomfort, equipment dependence, low sensitivity and inappropriate self-testing when detecting Helicobacter pylori infection, especially in resource-limited environments that are difficult to achieve rapid, accurate and efficient diagnosis.
Immunochromatography test strips were constructed using anti-HRC monoclonal antibodies labeled with quantum dot fluorescent microspheres. The HRC antigen in fecal samples was detected by double-anti-sandwich method to achieve rapid and accurate detection without requiring large equipment .
This method provides high sensitivity and high specificity, is suitable for home self-testing, is suitable for children and pregnant women, can quickly and accurately detect Helicobacter pylori antigen, reduces the risk of radioactive contamination, and is suitable for prognostic efficacy monitoring, and is of great clinical significance.
Smart Images

Figure CN118914541A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of biological detection, and in particular to a quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces and a preparation method thereof. Background Art
[0002] Helicobacter pylori (HP) is a Gram-negative bacterium that lives in the human gastric mucosa and has multiple flagella, spiral, S-shaped, and curved terminal segments. Helicobacter pylori is microaerophilic, has high nutritional requirements for growth, and grows slowly. Its colonies are small, needle-like, translucent, and non-hemolytic. HP has a special affinity for gastric epithelial cells. Under natural conditions, a large amount of HP mainly appears on the surface of gastric epithelial cells, in the intercellular spaces, and in the pits.
[0003] The overall household Helicobacter pylori (Hp) infection rate in my country is 71.2%, and the individual infection rate is 40.6%. Inadequate Hp infection and gastric cancer screening are key factors for the high incidence of gastric cancer in my country. Helicobacter pylori plays an important role in the occurrence and development of gastric cancer and MALT lymphoma. In 1994, WHO classified Helicobacter pylori as a Class 1 carcinogen. Studies have shown that the eradication of Helicobacter pylori can significantly reduce the incidence of sporadic gastric cancer. Given the high infection rate of Helicobacter pylori and limited medical resources, self-examination is helpful for diagnosis and timely treatment. Therefore, detecting the presence of HP antigens in digestive tract excreta has very practical clinical significance for the diagnosis of HP infection.
[0004] At present, there are two methods for diagnosing Helicobacter pylori infection, invasive and non-invasive, according to the type of sampling. Invasive examinations require biopsy specimens. Then the tissue samples are subjected to pathogen isolation and identification, rapid urease test or drug sensitivity test. Gastric biopsy specimens are the gold standard for testing Helicobacter pylori infection. However, invasive tests make patients feel uncomfortable and require specific instruments and trained professionals. Non-invasive tests include 13C and 14C breath tests, stool antigen tests and serum antibody tests, which are widely used for testing. However, 13C and 14C breath tests cannot distinguish Helicobacter pylori from other bacteria that can also produce urease, and breath tests require special equipment, waste requires special treatment, and there is radiation. It is not suitable for children and pregnant women to be examined, and it cannot be self-examined. The serological test of Helicobacter pylori IgG series antibodies uses blood as a specimen and needs to be completed in the laboratory. The test results cannot determine whether it is a current infection or a previous infection. It is not suitable for follow-up after treatment, monitoring the efficacy, and is not suitable for self-examination. Fecal antigen detection relies on lateral flow immunoassay (LFIA) and colloidal gold method, which have the advantages of rapidity (15-20 minutes), ease of use and low cost. However, the detection sensitivity of colloidal gold is low, which can easily lead to missed detection. Fluorescence immunochromatography (FICA) is a technology that can quantitatively detect the concentration of the analyte by detecting the intensity of the fluorescence signal based on immunochromatography technology. FICA has the characteristics of rapid detection, high sensitivity, strong stability and low cost. Its limitations are closely related to the selection of immunochromatography labeling materials. With the rapid development of nanomaterials, quantum dot nanomaterials (Quantum Dots, QDs) have super strong fluorescence signals, strong resistance to photobleaching, wide excitation spectrum, narrow emission spectrum half-peak width (size dependence), and surface functionalized quantum dot microspheres are very suitable for fluorescent labeling. The construction of a new type of quantum dot microsphere fluorescent immunochromatography makes it possible to detect antigens and antibodies. Summary of the invention
[0005] The purpose of the present invention is to provide a quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces and a preparation method thereof. The quantum dot fluorescent microsphere test strip prepared by the method has both high sensitivity and high specificity, and can quickly and accurately detect Helicobacter pylori antigens in fresh fecal samples; and can detect HP without any large-scale equipment, and has the advantages of fast and simple operation, accurate results, and home self-testing.
[0006] In order to achieve the above-mentioned object, the present invention provides a quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces, comprising a bottom plate, on the surface of which a sample pad, a conjugation pad, a nitrocellulose membrane and a water-absorbing pad are arranged in sequence from a sample application end, a detection line T and a quality control line C are provided on the nitrocellulose membrane, the conjugation pad is coated with an anti-Helicobacter pylori monoclonal antibody ~1 labeled with quantum dot fluorescent microspheres, the detection line T is coated with an anti-Helicobacter pylori monoclonal antibody ~2, and the quality control line C is coated with a sheep anti-mouse IgG polyclonal antibody.
[0007] The anti-Helicobacter pylori monoclonal antibody-1 and the anti-Helicobacter pylori monoclonal antibody-2 can be the same monoclonal antibody or different monoclonal antibodies.
[0008] Furthermore, the detection line T is close to one side of the conjugate pad, and the quality control line C is close to one side of the absorbent pad.
[0009] Furthermore, the test strip is used to detect Helicobacter pylori antigens in a sample.
[0010] Preferably, the sample is fresh human feces; approximately 30 mg to 60 mg of the feces sample is placed in a sample diluent and mixed evenly.
[0011] Preferably, the base plate is a PVC base plate.
[0012] In order to achieve the above object, the present invention also provides a method for preparing the above quantum dot fluorescent microsphere immunochromatographic test strip, comprising the following steps:
[0013] S1, spraying the pretreated binding pad with a solution of anti-Helicobacter pylori monoclonal antibody-1 labeled with quantum dot fluorescent microspheres to prepare a binding pad containing anti-Helicobacter pylori monoclonal antibody-1, i.e., a gold-labeled pad;
[0014] S2, using a gold marker to draw lines on the test line T and the quality control line C of the nitrocellulose membrane, respectively, embedding the anti-Helicobacter pylori monoclonal antibody ~2 and the goat anti-mouse IgG polyclonal antibody to prepare the coated nitrocellulose membrane;
[0015] S3, the pretreated sample pad, the gold label pad prepared in step S1, the coated nitrocellulose membrane prepared in step S2, and the absorbent pad are sequentially pasted on the bottom plate, and cut to obtain an immunochromatographic test strip.
[0016] Furthermore, in step S1, the conjugate pad is pretreated with a buffer, the buffer is selected from a combination of one or more of PB buffer, Tris-HCL buffer, and borate buffer, and the concentration of the buffer is 10-50 mM.
[0017] Furthermore, the specific steps of the pretreatment are: soaking the conjugate pad in a buffer solution for 0.5 to 1 hour, taking it out and drying it at 37° C. to 56° C.
[0018] Furthermore, in step S3, the sample pad is pretreated with a buffer selected from a combination of one or more of PB buffer, Tris-HCL buffer, glycine buffer, borate buffer and citric acid-phosphate buffer, and the concentration of the buffer is 10-100 mM.
[0019] The solvent of the pretreatment buffer is pure water; the pH value of the pretreatment buffer can be adjusted using various commonly used pH adjusters in the art.
[0020] Furthermore, in order to make the kit have better sensitivity and color development effect, the buffer solution also includes Tween 20 and NaCl, the concentration of Tween 20 in the buffer solution is 0.1-5.0 mg / mL, and the concentration of NaCl in the buffer solution is 0.1-10 mg / mL.
[0021] Compared with the prior art, the present invention has the following advantages:
[0022] The invention is based on quantum dot fluorescent microspheres to construct a Helicobacter pylori antigen detection reagent strip using a double antibody sandwich method with anti-Helicobacter pylori monoclonal antibodies. The quantum dot fluorescent microsphere detection test strip has both high sensitivity and high specificity, and can quickly and accurately detect Helicobacter pylori antigens in fresh fecal samples. The detection method can detect HP without any large-scale equipment, has the advantages of fast and simple operation, accurate results, convenience for immediate and rapid bedside testing, no radioactive pollution, suitability for pregnant women, children and other people who are not suitable for breath tests, convenience for prognosis and efficacy monitoring, long marker storage time, etc. In addition, it is also conducive to Helicobacter pylori self-testing at home, and helps to screen and diagnose HP early, has important application prospects for Helicobacter pylori antigen detection in feces, and has great clinical significance for the prevention and treatment of gastritis and gastric cancer caused by gastric Helicobacter pylori. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 This is a schematic diagram of the structure of the quantum dot fluorescent microsphere immunochromatographic test strip and a schematic diagram of the reaction principle in Example 1;
[0024] Figure 2 It is a comparison chart of the sensitivity results of the commercial colloidal gold test paper FLIA and the quantum dot fluorescent microsphere immunochromatographic test strip of Example 2;
[0025] Figure 3 This is a graph showing the specificity results of the quantum dot fluorescent microsphere immunochromatographic test strip in Example 3;
[0026] Figure 4This is a schematic diagram of the test results of a clinical Helicobacter pylori negative sample and a positive sample in Example 4;
[0027] Figure 1 Middle: 1. Sample pad, 2. Conjugate pad, 3. Absorbent pad, 4. Test line T, 5. Quality control line C, 6. Nitrocellulose membrane, 7. Bottom plate. DETAILED DESCRIPTION
[0028] The present invention will be further described below in conjunction with the accompanying drawings and specific embodiments.
[0029] Unless otherwise specified, the experimental methods used in the following examples are conventional methods.
[0030] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.
[0031] The main reagents used below, such as anti-Helicobacter pylori monoclonal antibody ~1, anti-Helicobacter pylori monoclonal antibody ~2 and Helicobacter pylori antigen quality control were purchased from Xibao Biotechnology (Shanghai) Co., Ltd.; sheep anti-mouse IgG polyclonal antibody was purchased from Feipeng Biotechnology Co., Ltd.; Helicobacter pylori antigen detection test paper (colloidal gold test paper ~ FLIA) was purchased from Nanjing Shenji Pharmaceutical Technology Co., Ltd.; quantum dot fluorescent nanospheres were purchased from Wuhan Jiayuan Quantum Dot Technology Development Co., Ltd.
[0032] Staphylococcus saprophyticus (BBA750-ATCC), Enterobacter hallii (700323-ATCC), Staphylococcus aureus (29213-ATCC), Escherichia coli (25922-ATCC), Pseudomonas aeruginosa (27853-ATCC), Enterococcus fusogenum (700327-ATCC) (the above six standard strains were provided by the hospital microbiology laboratory), human hemoglobin (1.0 mg / mL), one fecal Helicobacter pylori-negative sample, and one fecal Helicobacter pylori-positive sample (the samples were collected by the hospital physical examination center).
[0033] Embodiment 1
[0034] like Figure 1 As shown, a quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces comprises a bottom plate 7, on the surface of which a sample pad 1, a conjugation pad 2, a nitrocellulose membrane 6 and a water-absorbing pad 3 are arranged in sequence from the sample application end, a detection line T4 and a quality control line C5 are provided on the nitrocellulose membrane 6, the detection line T4 is close to the conjugation pad 2, and the quality control line C5 is close to the water-absorbing pad 3; the conjugation pad 2 is coated with an anti-Helicobacter pylori monoclonal antibody ~1 labeled with quantum dot fluorescent microspheres, the detection line T4 is coated with an anti-Helicobacter pylori monoclonal antibody ~2, and the quality control line C5 is coated with a sheep anti-mouse IgG polyclonal antibody.
[0035] The bottom plate 7 is a PVC bottom plate; one end of the binding pad 2 overlaps with the sample pad 1, and the other end overlaps with one end of the nitrocellulose membrane 6, and the other end of the nitrocellulose membrane 6 overlaps with the absorbent pad 3; the detection line T4 is 6mm away from the edge of the nitrocellulose membrane 6; the quality control line C5 is 12mm away from the edge of the nitrocellulose membrane 6; the distance between the detection line T4 and the quality control line C5 is 5mm.
[0036] The preparation method of the quantum dot fluorescent microsphere immunochromatographic test strip comprises the following steps:
[0037] S1, spraying the pretreated binding pad 2 with a solution of anti-Helicobacter pylori monoclonal antibody-1 labeled with quantum dot fluorescent microspheres to prepare a binding pad containing anti-Helicobacter pylori monoclonal antibody-1, i.e., a gold-labeled pad;
[0038] The specific steps of pretreatment of the conjugate pad 2 are as follows: soak the conjugate pad 2 in a buffer solution for 0.5 to 1 hour, take it out and place it at 37°C to
[0039] Dry at 56℃.
[0040] The buffer is selected from PB buffer, and taking 100 mL of buffer as an example, it comprises 20-50 mg disodium hydrogen phosphate, 200-300 mg sodium dihydrogen phosphate, 500-900 mg sodium chloride, 0.5-2 g bovine serum albumin, 0.010-0.030 g Tween, 1-5 g PEG2000, and 2-8 g sucrose;
[0041] The specific labeling scheme of the anti-Helicobacter pylori monoclonal antibody ~1 labeled with quantum dot fluorescent microspheres is as follows:
[0042] Take 50 μL quantum dot fluorescent nanospheres (made of ZnCdSe / ZnS, with an emission wavelength of 625±5 nm), add them to 300 μL 25 mM PB buffer (pH6-pH8), mix, centrifuge at 17700 g for 20 min, remove the supernatant, add 300 μL 25 mM PB buffer (pH6-pH8), mix by ultrasound, add EDC and NHS for activation for 30 min, centrifuge at 17700 g for 20 min, remove the supernatant, add 300 μL 25 mM PB buffer (pH6-pH8), mix by ultrasound, add 120 μL anti-Helicobacter pylori monoclonal antibody, react for 1-2 h, add BSA for blocking for 30-60 min, centrifuge at 17700 g for 20 min, remove the supernatant, add 300 μL 25 mM PB buffer (pH 6-pH 8), ultrasonically mix, centrifuge at 17700g for 20 min, remove the supernatant, add the resuspending solution to resuspend, and refrigerate at 4℃ for later use.
[0043] The reconstitution solution in the labeling scheme is composed of 10 mM PB buffer, 0.5% sodium chloride, 0.5% bovine serum albumin, 0.5% PEG2000, and 5% sucrose.
[0044] S2, using a gold marker to draw lines on the test line T4 and the quality control line C5 of the nitrocellulose membrane 6, respectively, embedding the anti-Helicobacter pylori monoclonal antibody ~2 and the goat anti-mouse IgG polyclonal antibody to obtain a coated nitrocellulose membrane;
[0045] S3, the pretreated sample pad 1, the gold label pad prepared in step S1, the coated nitrocellulose membrane prepared in step S2, and the absorbent pad 3 are sequentially pasted on the bottom plate 7, and cut to obtain an immunochromatographic test strip, the principle reaction diagram of which is shown in FIG. Figure 1 As shown, from Figure 1 It can be seen from the figure that if the sample contains Helicobacter pylori antigen, it will be chromatographed to the binding pad 2 with the sample, and after binding with the quantum dot-labeled anti-Helicobacter pylori monoclonal antibody ~1, it will continue to chromatograph to the T line position on the NC membrane.
[0046] The anti-Helicobacter pylori monoclonal antibody ~2 is embedded in the line, forming a double antibody sandwich structure and precipitating at the T line position; the remaining quantum dot-labeled anti-Helicobacter pylori monoclonal antibody ~1 continues to chromatograph to the position coated with the goat anti-mouse IgG polyclonal antibody, and is bound and captured by the goat anti-mouse IgG polyclonal antibody. The reaction is carried out for 15 to 20 minutes, and the results are observed using a portable ultraviolet lamp with an excitation spectrum of 365nm. If the T line and the C line show red bands at the same time, it is a positive result; if the T line has no red bands and the C line has red bands, the result is negative; if both the T line and the C line do not show red bands, it is an invalid result.
[0047] Embodiment 2
[0048] The sensitivity of the quantum dot fluorescent microsphere immunochromatographic test strip is tested as follows:
[0049] Take the quantum dot fluorescent microsphere immunochromatographic test strip prepared in Example 1, place the reagent strip on a horizontal platform, and detect 0 CFU / mL, 2.5*10 3 CFU / mL, 5.0*10 3 CFU / mL, 1.0*10 4 CFU / mL, 2.5*10 4 CFU / mL, 5.0*10 4 CFU / mL, 1.0*10 5 CFU / mL, 2.5*10 5 CFU / mL, 5.0*10 5 CFU / mL, 1.0*10 6 CFU / mL, 2.5*106 CFU / mL, 5.0*10 6 CFU / mL, 1.0*10 7 CFU / mL, 1.0*10 8 CFU / mL of Helicobacter pylori liquid, each concentration was repeated 3 times. Use a pipette to draw 70μL of sample liquid and add it to sample pad 1. 15-20 minutes after adding the sample, use a portable ultraviolet lamp (365nm) to read the results. If it is positive, both the T line and the C line will have strips. As the bacterial concentration decreases, the color of the T line gradually becomes lighter; if it is negative, there will be no strips on the T line and there will be strips on the C line. See the results. Figure 2 .
[0050] from Figure 2 It can be seen that the commercial colloidal gold test strip and the test strip of the present invention are used to detect the same batch of Helicobacter pylori liquid with different concentrations. The test strip of the present invention has a high 4 CFU / mL, the T line has a band, while the commercial colloidal gold test paper is 2.5*10 5 CFU / mL, the T line shows a band, indicating that the test strip of the present invention has higher sensitivity, which is 10 times higher than the sensitivity of the colloidal gold method.
[0051] Embodiment 3
[0052] The specificity of the quantum dot fluorescent microsphere immunochromatographic test strip is tested as follows:
[0053] Take the quantum dot fluorescent microsphere immunochromatographic test strip prepared in Example 1, place the test strip on a horizontal platform, and detect saprophytic Staphylococcus (BBA750-ATCC), Enterobacter hallii (700323-ATCC), Staphylococcus aureus (29213-ATCC), Escherichia coli (25922-ATCC), Pseudomonas aeruginosa (27853-ATCC), Enterococcus fusae (700327-ATCC), and six standard bacteria. All of them were diluted with sample diluent, and the concentration was 1.0*10 8 CFU / mL, human hemoglobin was diluted to a concentration of 1.0 mg / mL with sample diluent, and each test was repeated 3 times. 70 μL of sample solution was drawn with a pipette and added to sample pad 1. 15 to 20 minutes after the sample was added, the results were read with a portable ultraviolet lamp (365 nm). Figure 3 shown.
[0054] from Figure 3It can be seen that when Helicobacter pylori is added to the sample diluent, bands appear on the T line and the C line. When Staphylococcus saprophyticus, Enterobacter hallii, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Enterococcus pyogenes, and human hemoglobin are added, there is no band on the T line and there is a band on the C line. The results show that the test strip prepared by the present invention has high specificity.
[0055] Embodiment 4
[0056] The specific process of testing the stool sample of the quantum dot fluorescent microsphere immunochromatographic test strip is as follows:
[0057] Take the quantum dot fluorescent microsphere immunochromatographic test strip prepared in Example 1, place the test strip on a horizontal surface, and test one fecal Helicobacter pylori negative sample and one fecal Helicobacter pylori positive sample. Use a pipette to draw 70 μL of the sample solution and add it to the sample pad 1. 15 to 20 minutes after the sample is added, read the result with a portable ultraviolet lamp (365 nm). The result is as follows: Figure 4 When testing a fecal Helicobacter pylori negative sample, the T line has no bands, and the C line has bands (see Figure 4 In the middle A), when testing a fecal Helicobacter pylori-positive sample, both T and C lines showed bands (see Figure 4 (B) The results show that the immunochromatographic test strip prepared by the present invention can be applied to the detection of Helicobacter pylori antigen in stool specimens, and has important application prospects for the detection of Helicobacter pylori antigen in stool specimens.
Claims
1. A quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces, comprising a bottom plate (7), a sample pad (1), a binding pad (2), a nitrocellulose membrane (6) and a water-absorbing pad (3) arranged in sequence on the surface of the bottom plate (7) from the sample application end, a detection line T (4) and a quality control line C (5) being provided on the nitrocellulose membrane (6), It is characterized in that The binding pad (2) is coated with anti-Helicobacter pylori monoclonal antibody ~1 labeled with quantum dot fluorescent microspheres, the detection line T (4) is coated with anti-Helicobacter pylori monoclonal antibody ~2, and the quality control line C (5) is coated with goat anti-mouse IgG polyclonal antibody.
2. The quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces according to claim 1, characterized in that: The detection line T (4) is close to one side of the binding pad (2), and the quality control line C (5) is close to one side of the water absorption pad (3).
3. A quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces according to claim 1 or 2, characterized in that: The test strip is used for detecting Helicobacter pylori antigen in a sample.
4. The quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces according to claim 3, characterized in that: The sample is fresh human feces.
5. A quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces according to claim 1 or 2, characterized in that: The bottom plate (7) is a PVC bottom plate.
6. The method for preparing the quantum dot fluorescent microsphere immunochromatographic test strip according to any one of claims 1 to 5, characterized in that: The steps include: S1, spraying the pretreated binding pad (2) with the anti-Helicobacter pylori monoclonal antibody-1 solution labeled with quantum dot fluorescent microspheres to obtain a binding pad containing the anti-Helicobacter pylori monoclonal antibody-1, i.e., a gold-labeled pad; S2, using a gold marker to draw lines on the test line T (4) and the quality control line C (5) of the nitrocellulose membrane (6), respectively, and embedding the anti-Helicobacter pylori monoclonal antibody ~2 and the goat anti-mouse IgG polyclonal antibody to obtain a coated nitrocellulose membrane; S3, sequentially pasting the pretreated sample pad (1), the gold label pad prepared in step S1, the coated nitrocellulose membrane prepared in step S2, and the absorbent pad (3) on the bottom plate (7), and cutting to obtain an immunochromatographic test strip.
7. The method for preparing a quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces according to claim 6, characterized in that: In step S1, the conjugate pad (2) is pretreated with a buffer, wherein the buffer is selected from a combination of one or more of a PB buffer, a Tris-HCl buffer, and a borate buffer, and the concentration of the buffer is 10-50 mM.
8. The method for preparing a quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces according to claim 7, characterized in that: The specific steps of the pretreatment are: soaking the binding pad (2) in a buffer solution for 0.5 to 1 hour, taking it out and drying it at 37° C. to 56° C.
9. The method for preparing a quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces according to claim 6, characterized in that: In step S3, the sample pad (1) is pretreated with a buffer, wherein the buffer is selected from a combination of one or more of PB buffer, Tris-HCL buffer, glycine buffer, borate buffer and citrate-phosphate buffer, and the concentration of the buffer is 10-100 mM.
10. The method for preparing a quantum dot fluorescent microsphere immunochromatographic test strip for detecting Helicobacter pylori in feces according to claim 7 or 9, characterized in that: The buffer further comprises Tween 20 and NaCl, wherein the concentration of Tween 20 in the buffer is 0.1-5.0 mg / mL, and the concentration of NaCl in the buffer is 0.1-10 mg / mL.
Citation Information
Patent Citations
Fluorescent microsphere immunochromatographic test strip for triple quantitative detection of fusarium toxin, preparation method and application of Fluorescent microsphere immunochromatographic test strip
CN111089956A
Quantum dot nanosphere immunochromatography test strip for rapidly detecting new coronavirus
CN114264819A
Helicobacter pylori antigen colloidal gold detection reagent strip
CN115267185A
Kit for testing helicobacter pylori antigen in oral cavity and use
WO2024131129A1
Cited By
Quantum dot fluorescent microsphere immunochromatography test paper, preparation method thereof and application of quantum dot fluorescent microsphere immunochromatography test paper in fish meat structure detection
CN120610004A
Helicobacter pylori antigen chromatography detection test strip, kit and application
CN121027514A
